Senex Biotechnology, Inc.
Records under this name other than the patents Senex Biotechnology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 5 of 5 · Back to Senex Biotechnology, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,014,906 | Quinoline-Based Compounds and Methods of Inhibiting CDK8/19 Formerly held In force · High confidence | In force | High confidence | |
| US 12,281,080 | Quinoline-Based Compounds and Methods of Inhibiting CDK8/19 Formerly held In force · High confidence | In force | High confidence | |
| US 11,572,369 | Bicyclic Pyridine Compositions and Methods of Using the Same for Cancer Therapy Formerly held In force · High confidence | In force | High confidence | |
| US 10,584,369 | Cell-based methods for measuring activity of a protein inhibitor Lapsed on the fee record Ended Mar 10, 2024 · USPTO record | Lapsed on the fee record | Ended Mar 10, 2024 | USPTO record |
| US 8,592,147 | High-content screening for drugs against cancer and age-related diseases Lapsed on the fee record Ended Nov 26, 2021 · USPTO record | Lapsed on the fee record | Ended Nov 26, 2021 | USPTO record |